Report Cover

Global Nimesulide Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Tablets
    Capsule
    Granules
    Other

Segment by Application
    Chronic Arthritis
    Primary Dysmenorrhea
    Traumatic Pain
    Post-Operative Pain
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Helsinn
    Therabel
    Boehringer Ingelheim
    Merck
    Roche
    Novartis
    Medea Research
    Chinoin
    GSK
    Alter
    Bayer
    Rafa Laboratories
    Grunenthal
    Pfizer
    Sanofi
    Italfarmaco
    Lepu Pharmaceutical
    Nanchang Feihong Pharmaceutical
    Sinopharm
    Guangdong Longxin Pharmaceutical
    Kangzhi Pharmaceutical
    Hubei Shubang Pharmaceutical
    Mudanjiang Lingtai Pharmaceutical
    Guizhou Jisheng Pharmaceutical
    Tianjin Hezhi Pharmaceutical Group
    Guangdong Yishu Pharmaceutical
    Guangzhou Baiyunshan Pharmaceutical
    Hainan Huluwa Pharmaceutical
    Nanjing Zhengke Pharmaceutical
1 Nimesulide Market Overview
    1.1 Product Overview and Scope of Nimesulide
    1.2 Nimesulide Segment by Type
        1.2.1 Global Nimesulide Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Tablets
        1.2.3 Capsule
        1.2.4 Granules
        1.2.5 Other
    1.3 Nimesulide Segment by Application
        1.3.1 Nimesulide Sales Comparison by Application: (2021-2027)
        1.3.2 Chronic Arthritis
        1.3.3 Primary Dysmenorrhea
        1.3.4 Traumatic Pain
        1.3.5 Post-Operative Pain
        1.3.6 Other
    1.4 Global Nimesulide Market Size Estimates and Forecasts
        1.4.1 Global Nimesulide Revenue 2016-2027
        1.4.2 Global Nimesulide Sales 2016-2027
        1.4.3 Nimesulide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Nimesulide Market Competition by Manufacturers
    2.1 Global Nimesulide Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Nimesulide Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Nimesulide Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Nimesulide Manufacturing Sites, Area Served, Product Type
    2.5 Nimesulide Market Competitive Situation and Trends
        2.5.1 Nimesulide Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Nimesulide Players Market Share by Revenue
        2.5.3 Global Nimesulide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nimesulide Retrospective Market Scenario by Region
    3.1 Global Nimesulide Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Nimesulide Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Nimesulide Market Facts & Figures by Country
        3.3.1 North America Nimesulide Sales by Country
        3.3.2 North America Nimesulide Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Nimesulide Market Facts & Figures by Country
        3.4.1 Europe Nimesulide Sales by Country
        3.4.2 Europe Nimesulide Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Nimesulide Market Facts & Figures by Region
        3.5.1 Asia Pacific Nimesulide Sales by Region
        3.5.2 Asia Pacific Nimesulide Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Nimesulide Market Facts & Figures by Country
        3.6.1 Latin America Nimesulide Sales by Country
        3.6.2 Latin America Nimesulide Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Nimesulide Market Facts & Figures by Country
        3.7.1 Middle East and Africa Nimesulide Sales by Country
        3.7.2 Middle East and Africa Nimesulide Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Nimesulide Historic Market Analysis by Type
    4.1 Global Nimesulide Sales Market Share by Type (2016-2021)
    4.2 Global Nimesulide Revenue Market Share by Type (2016-2021)
    4.3 Global Nimesulide Price by Type (2016-2021)

5 Global Nimesulide Historic Market Analysis by Application
    5.1 Global Nimesulide Sales Market Share by Application (2016-2021)
    5.2 Global Nimesulide Revenue Market Share by Application (2016-2021)
    5.3 Global Nimesulide Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Helsinn
        6.1.1 Helsinn Corporation Information
        6.1.2 Helsinn Description and Business Overview
        6.1.3 Helsinn Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Helsinn Product Portfolio
        6.1.5 Helsinn Recent Developments/Updates
    6.2 Therabel
        6.2.1 Therabel Corporation Information
        6.2.2 Therabel Description and Business Overview
        6.2.3 Therabel Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Therabel Product Portfolio
        6.2.5 Therabel Recent Developments/Updates
    6.3 Boehringer Ingelheim
        6.3.1 Boehringer Ingelheim Corporation Information
        6.3.2 Boehringer Ingelheim Description and Business Overview
        6.3.3 Boehringer Ingelheim Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Boehringer Ingelheim Product Portfolio
        6.3.5 Boehringer Ingelheim Recent Developments/Updates
    6.4 Merck
        6.4.1 Merck Corporation Information
        6.4.2 Merck Description and Business Overview
        6.4.3 Merck Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Merck Product Portfolio
        6.4.5 Merck Recent Developments/Updates
    6.5 Roche
        6.5.1 Roche Corporation Information
        6.5.2 Roche Description and Business Overview
        6.5.3 Roche Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Roche Product Portfolio
        6.5.5 Roche Recent Developments/Updates
    6.6 Novartis
        6.6.1 Novartis Corporation Information
        6.6.2 Novartis Description and Business Overview
        6.6.3 Novartis Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Novartis Product Portfolio
        6.6.5 Novartis Recent Developments/Updates
    6.7 Medea Research
        6.6.1 Medea Research Corporation Information
        6.6.2 Medea Research Description and Business Overview
        6.6.3 Medea Research Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Medea Research Product Portfolio
        6.7.5 Medea Research Recent Developments/Updates
    6.8 Chinoin
        6.8.1 Chinoin Corporation Information
        6.8.2 Chinoin Description and Business Overview
        6.8.3 Chinoin Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Chinoin Product Portfolio
        6.8.5 Chinoin Recent Developments/Updates
    6.9 GSK
        6.9.1 GSK Corporation Information
        6.9.2 GSK Description and Business Overview
        6.9.3 GSK Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 GSK Product Portfolio
        6.9.5 GSK Recent Developments/Updates
    6.10 Alter
        6.10.1 Alter Corporation Information
        6.10.2 Alter Description and Business Overview
        6.10.3 Alter Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Alter Product Portfolio
        6.10.5 Alter Recent Developments/Updates
    6.11 Bayer
        6.11.1 Bayer Corporation Information
        6.11.2 Bayer Nimesulide Description and Business Overview
        6.11.3 Bayer Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Bayer Product Portfolio
        6.11.5 Bayer Recent Developments/Updates
    6.12 Rafa Laboratories
        6.12.1 Rafa Laboratories Corporation Information
        6.12.2 Rafa Laboratories Nimesulide Description and Business Overview
        6.12.3 Rafa Laboratories Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Rafa Laboratories Product Portfolio
        6.12.5 Rafa Laboratories Recent Developments/Updates
    6.13 Grunenthal
        6.13.1 Grunenthal Corporation Information
        6.13.2 Grunenthal Nimesulide Description and Business Overview
        6.13.3 Grunenthal Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Grunenthal Product Portfolio
        6.13.5 Grunenthal Recent Developments/Updates
    6.14 Pfizer
        6.14.1 Pfizer Corporation Information
        6.14.2 Pfizer Nimesulide Description and Business Overview
        6.14.3 Pfizer Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Pfizer Product Portfolio
        6.14.5 Pfizer Recent Developments/Updates
    6.15 Sanofi
        6.15.1 Sanofi Corporation Information
        6.15.2 Sanofi Nimesulide Description and Business Overview
        6.15.3 Sanofi Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Sanofi Product Portfolio
        6.15.5 Sanofi Recent Developments/Updates
    6.16 Italfarmaco
        6.16.1 Italfarmaco Corporation Information
        6.16.2 Italfarmaco Nimesulide Description and Business Overview
        6.16.3 Italfarmaco Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Italfarmaco Product Portfolio
        6.16.5 Italfarmaco Recent Developments/Updates
    6.17 Lepu Pharmaceutical
        6.17.1 Lepu Pharmaceutical Corporation Information
        6.17.2 Lepu Pharmaceutical Nimesulide Description and Business Overview
        6.17.3 Lepu Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Lepu Pharmaceutical Product Portfolio
        6.17.5 Lepu Pharmaceutical Recent Developments/Updates
    6.18 Nanchang Feihong Pharmaceutical
        6.18.1 Nanchang Feihong Pharmaceutical Corporation Information
        6.18.2 Nanchang Feihong Pharmaceutical Nimesulide Description and Business Overview
        6.18.3 Nanchang Feihong Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 Nanchang Feihong Pharmaceutical Product Portfolio
        6.18.5 Nanchang Feihong Pharmaceutical Recent Developments/Updates
    6.19 Sinopharm
        6.19.1 Sinopharm Corporation Information
        6.19.2 Sinopharm Nimesulide Description and Business Overview
        6.19.3 Sinopharm Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Sinopharm Product Portfolio
        6.19.5 Sinopharm Recent Developments/Updates
    6.20 Guangdong Longxin Pharmaceutical
        6.20.1 Guangdong Longxin Pharmaceutical Corporation Information
        6.20.2 Guangdong Longxin Pharmaceutical Nimesulide Description and Business Overview
        6.20.3 Guangdong Longxin Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Guangdong Longxin Pharmaceutical Product Portfolio
        6.20.5 Guangdong Longxin Pharmaceutical Recent Developments/Updates
    6.21 Kangzhi Pharmaceutical
        6.21.1 Kangzhi Pharmaceutical Corporation Information
        6.21.2 Kangzhi Pharmaceutical Nimesulide Description and Business Overview
        6.21.3 Kangzhi Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Kangzhi Pharmaceutical Product Portfolio
        6.21.5 Kangzhi Pharmaceutical Recent Developments/Updates
    6.22 Hubei Shubang Pharmaceutical
        6.22.1 Hubei Shubang Pharmaceutical Corporation Information
        6.22.2 Hubei Shubang Pharmaceutical Nimesulide Description and Business Overview
        6.22.3 Hubei Shubang Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Hubei Shubang Pharmaceutical Product Portfolio
        6.22.5 Hubei Shubang Pharmaceutical Recent Developments/Updates
    6.23 Mudanjiang Lingtai Pharmaceutical
        6.23.1 Mudanjiang Lingtai Pharmaceutical Corporation Information
        6.23.2 Mudanjiang Lingtai Pharmaceutical Nimesulide Description and Business Overview
        6.23.3 Mudanjiang Lingtai Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Mudanjiang Lingtai Pharmaceutical Product Portfolio
        6.23.5 Mudanjiang Lingtai Pharmaceutical Recent Developments/Updates
    6.24 Guizhou Jisheng Pharmaceutical
        6.24.1 Guizhou Jisheng Pharmaceutical Corporation Information
        6.24.2 Guizhou Jisheng Pharmaceutical Nimesulide Description and Business Overview
        6.24.3 Guizhou Jisheng Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Guizhou Jisheng Pharmaceutical Product Portfolio
        6.24.5 Guizhou Jisheng Pharmaceutical Recent Developments/Updates
    6.25 Tianjin Hezhi Pharmaceutical Group
        6.25.1 Tianjin Hezhi Pharmaceutical Group Corporation Information
        6.25.2 Tianjin Hezhi Pharmaceutical Group Nimesulide Description and Business Overview
        6.25.3 Tianjin Hezhi Pharmaceutical Group Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.25.4 Tianjin Hezhi Pharmaceutical Group Product Portfolio
        6.25.5 Tianjin Hezhi Pharmaceutical Group Recent Developments/Updates
    6.26 Guangdong Yishu Pharmaceutical
        6.26.1 Guangdong Yishu Pharmaceutical Corporation Information
        6.26.2 Guangdong Yishu Pharmaceutical Nimesulide Description and Business Overview
        6.26.3 Guangdong Yishu Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.26.4 Guangdong Yishu Pharmaceutical Product Portfolio
        6.26.5 Guangdong Yishu Pharmaceutical Recent Developments/Updates
    6.27 Guangzhou Baiyunshan Pharmaceutical
        6.27.1 Guangzhou Baiyunshan Pharmaceutical Corporation Information
        6.27.2 Guangzhou Baiyunshan Pharmaceutical Nimesulide Description and Business Overview
        6.27.3 Guangzhou Baiyunshan Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.27.4 Guangzhou Baiyunshan Pharmaceutical Product Portfolio
        6.27.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
    6.28 Hainan Huluwa Pharmaceutical
        6.28.1 Hainan Huluwa Pharmaceutical Corporation Information
        6.28.2 Hainan Huluwa Pharmaceutical Nimesulide Description and Business Overview
        6.28.3 Hainan Huluwa Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.28.4 Hainan Huluwa Pharmaceutical Product Portfolio
        6.28.5 Hainan Huluwa Pharmaceutical Recent Developments/Updates
    6.29 Nanjing Zhengke Pharmaceutical
        6.29.1 Nanjing Zhengke Pharmaceutical Corporation Information
        6.29.2 Nanjing Zhengke Pharmaceutical Nimesulide Description and Business Overview
        6.29.3 Nanjing Zhengke Pharmaceutical Nimesulide Sales, Revenue and Gross Margin (2016-2021)
        6.29.4 Nanjing Zhengke Pharmaceutical Product Portfolio
        6.29.5 Nanjing Zhengke Pharmaceutical Recent Developments/Updates

7 Nimesulide Manufacturing Cost Analysis
    7.1 Nimesulide Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Nimesulide
    7.4 Nimesulide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Nimesulide Distributors List
    8.3 Nimesulide Customers

9 Nimesulide Market Dynamics
    9.1 Nimesulide Industry Trends
    9.2 Nimesulide Growth Drivers
    9.3 Nimesulide Market Challenges
    9.4 Nimesulide Market Restraints

10 Global Market Forecast
    10.1 Nimesulide Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Nimesulide by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Nimesulide by Type (2022-2027)
    10.2 Nimesulide Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Nimesulide by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Nimesulide by Application (2022-2027)
    10.3 Nimesulide Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Nimesulide by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Nimesulide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Nimesulide Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Nimesulide Sales (KG) Comparison by Application (2021-2027) Table 3. Global Nimesulide Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Nimesulide Covered in This Study Table 5. Global Nimesulide Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Nimesulide Sales Share by Manufacturers (2016-2021) Table 7. Global Nimesulide Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Nimesulide Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Nimesulide Average Price (US$/G) of Key Manufacturers (2016-2021) Table 10. Manufacturers Nimesulide Manufacturing Sites and Area Served Table 11. Manufacturers Nimesulide Product Type Table 12. Global Nimesulide Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Nimesulide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nimesulide as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Nimesulide Sales by Region (2016-2021) & (KG) Table 16. Global Nimesulide Sales Market Share by Region (2016-2021) Table 17. Global Nimesulide Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Nimesulide Sales by Country (2016-2021) & (KG) Table 19. North America Nimesulide Sales Market Share by Country (2016-2021) Table 20. North America Nimesulide Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Nimesulide Revenue Market Share by Country (2016-2021) Table 22. Europe Nimesulide Sales by Country (2016-2021) & (KG) Table 23. Europe Nimesulide Sales Market Share by Country (2016-2021) Table 24. Europe Nimesulide Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Nimesulide Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Nimesulide Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Nimesulide Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Nimesulide Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Nimesulide Revenue Market Share by Region (2016-2021) Table 30. Latin America Nimesulide Sales by Country (2016-2021) & (KG) Table 31. Latin America Nimesulide Sales Market Share by Country (2016-2021) Table 32. Latin America Nimesulide Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Nimesulide Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Nimesulide Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Nimesulide Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Nimesulide Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Nimesulide Revenue Market Share by Country (2016-2021) Table 38. Global Nimesulide Sales (KG) by Type (2016-2021) Table 39. Global Nimesulide Sales Market Share by Type (2016-2021) Table 40. Global Nimesulide Revenue (Million US$) by Type (2016-2021) Table 41. Global Nimesulide Revenue Share by Type (2016-2021) Table 42. Global Nimesulide Price (US$/G) by Type (2016-2021) Table 43. Global Nimesulide Sales (KG) by Application (2016-2021) Table 44. Global Nimesulide Sales Market Share by Application (2016-2021) Table 45. Global Nimesulide Revenue (Million US$) by Application (2016-2021) Table 46. Global Nimesulide Revenue Share by Application (2016-2021) Table 47. Global Nimesulide Price (US$/G) by Application (2016-2021) Table 48. Helsinn Corporation Information Table 49. Helsinn Description and Business Overview Table 50. Helsinn Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 51. Helsinn Nimesulide Product Table 52. Helsinn Recent Developments/Updates Table 53. Therabel Corporation Information Table 54. Therabel Description and Business Overview Table 55. Therabel Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 56. Therabel Nimesulide Product Table 57. Therabel Recent Developments/Updates Table 58. Boehringer Ingelheim Corporation Information Table 59. Boehringer Ingelheim Description and Business Overview Table 60. Boehringer Ingelheim Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 61. Boehringer Ingelheim Nimesulide Product Table 62. Boehringer Ingelheim Recent Developments/Updates Table 63. Merck Corporation Information Table 64. Merck Description and Business Overview Table 65. Merck Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 66. Merck Nimesulide Product Table 67. Merck Recent Developments/Updates Table 68. Roche Corporation Information Table 69. Roche Description and Business Overview Table 70. Roche Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 71. Roche Nimesulide Product Table 72. Roche Recent Developments/Updates Table 73. Novartis Corporation Information Table 74. Novartis Description and Business Overview Table 75. Novartis Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 76. Novartis Nimesulide Product Table 77. Novartis Recent Developments/Updates Table 78. Medea Research Corporation Information Table 79. Medea Research Description and Business Overview Table 80. Medea Research Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 81. Medea Research Nimesulide Product Table 82. Medea Research Recent Developments/Updates Table 83. Chinoin Corporation Information Table 84. Chinoin Description and Business Overview Table 85. Chinoin Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 86. Chinoin Nimesulide Product Table 87. Chinoin Recent Developments/Updates Table 88. GSK Corporation Information Table 89. GSK Description and Business Overview Table 90. GSK Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 91. GSK Nimesulide Product Table 92. GSK Recent Developments/Updates Table 93. Alter Corporation Information Table 94. Alter Description and Business Overview Table 95. Alter Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 96. Alter Nimesulide Product Table 97. Alter Recent Developments/Updates Table 98. Bayer Corporation Information Table 99. Bayer Description and Business Overview Table 100. Bayer Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 101. Bayer Nimesulide Product Table 102. Bayer Recent Developments/Updates Table 103. Rafa Laboratories Corporation Information Table 104. Rafa Laboratories Description and Business Overview Table 105. Rafa Laboratories Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 106. Rafa Laboratories Nimesulide Product Table 107. Rafa Laboratories Recent Developments/Updates Table 108. Grunenthal Corporation Information Table 109. Grunenthal Description and Business Overview Table 110. Grunenthal Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 111. Grunenthal Nimesulide Product Table 112. Grunenthal Recent Developments/Updates Table 113. Pfizer Corporation Information Table 114. Pfizer Description and Business Overview Table 115. Pfizer Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 116. Pfizer Nimesulide Product Table 117. Pfizer Recent Developments/Updates Table 118. Sanofi Corporation Information Table 119. Sanofi Description and Business Overview Table 120. Sanofi Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 121. Sanofi Nimesulide Product Table 122. Sanofi Recent Developments/Updates Table 123. Italfarmaco Corporation Information Table 124. Italfarmaco Description and Business Overview Table 125. Italfarmaco Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 126. Italfarmaco Nimesulide Product Table 127. Italfarmaco Recent Developments/Updates Table 128. Lepu Pharmaceutical Corporation Information Table 129. Lepu Pharmaceutical Description and Business Overview Table 130. Lepu Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 131. Lepu Pharmaceutical Nimesulide Product Table 132. Lepu Pharmaceutical Recent Developments/Updates Table 133. Nanchang Feihong Pharmaceutical Corporation Information Table 134. Nanchang Feihong Pharmaceutical Description and Business Overview Table 135. Nanchang Feihong Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 136. Nanchang Feihong Pharmaceutical Nimesulide Product Table 137. Nanchang Feihong Pharmaceutical Recent Developments/Updates Table 138. Sinopharm Corporation Information Table 139. Sinopharm Description and Business Overview Table 140. Sinopharm Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 141. Sinopharm Nimesulide Product Table 142. Sinopharm Recent Developments/Updates Table 143. Guangdong Longxin Pharmaceutical Corporation Information Table 144. Guangdong Longxin Pharmaceutical Description and Business Overview Table 145. Guangdong Longxin Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 146. Guangdong Longxin Pharmaceutical Nimesulide Product Table 147. Guangdong Longxin Pharmaceutical Recent Developments/Updates Table 148. Kangzhi Pharmaceutical Corporation Information Table 149. Kangzhi Pharmaceutical Description and Business Overview Table 150. Kangzhi Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 151. Kangzhi Pharmaceutical Nimesulide Product Table 152. Kangzhi Pharmaceutical Recent Developments/Updates Table 153. Hubei Shubang Pharmaceutical Corporation Information Table 154. Hubei Shubang Pharmaceutical Description and Business Overview Table 155. Hubei Shubang Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 156. Hubei Shubang Pharmaceutical Nimesulide Product Table 157. Hubei Shubang Pharmaceutical Recent Developments/Updates Table 158. Mudanjiang Lingtai Pharmaceutical Corporation Information Table 159. Mudanjiang Lingtai Pharmaceutical Description and Business Overview Table 160. Mudanjiang Lingtai Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 161. Mudanjiang Lingtai Pharmaceutical Nimesulide Product Table 162. Mudanjiang Lingtai Pharmaceutical Recent Developments/Updates Table 163. Guizhou Jisheng Pharmaceutical Corporation Information Table 164. Guizhou Jisheng Pharmaceutical Description and Business Overview Table 165. Guizhou Jisheng Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 166. Guizhou Jisheng Pharmaceutical Nimesulide Product Table 167. Guizhou Jisheng Pharmaceutical Recent Developments/Updates Table 168. Tianjin Hezhi Pharmaceutical Group Corporation Information Table 169. Tianjin Hezhi Pharmaceutical Group Description and Business Overview Table 170. Tianjin Hezhi Pharmaceutical Group Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 171. Tianjin Hezhi Pharmaceutical Group Nimesulide Product Table 172. Tianjin Hezhi Pharmaceutical Group Recent Developments/Updates Table 173. Guangdong Yishu Pharmaceutical Corporation Information Table 174. Guangdong Yishu Pharmaceutical Description and Business Overview Table 175. Guangdong Yishu Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 176. Guangdong Yishu Pharmaceutical Nimesulide Product Table 177. Guangdong Yishu Pharmaceutical Recent Developments/Updates Table 178. Guangzhou Baiyunshan Pharmaceutical Corporation Information Table 179. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview Table 180. Guangzhou Baiyunshan Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 181. Guangzhou Baiyunshan Pharmaceutical Nimesulide Product Table 182. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates Table 183. Hainan Huluwa Pharmaceutical Corporation Information Table 184. Hainan Huluwa Pharmaceutical Description and Business Overview Table 185. Hainan Huluwa Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 186. Hainan Huluwa Pharmaceutical Nimesulide Product Table 187. Hainan Huluwa Pharmaceutical Recent Developments/Updates Table 188. Nanjing Zhengke Pharmaceutical Corporation Information Table 189. Nanjing Zhengke Pharmaceutical Description and Business Overview Table 190. Nanjing Zhengke Pharmaceutical Nimesulide Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 191. Nanjing Zhengke Pharmaceutical Nimesulide Product Table 192. Nanjing Zhengke Pharmaceutical Recent Developments/Updates Table 193. Production Base and Market Concentration Rate of Raw Material Table 194. Key Suppliers of Raw Materials Table 195. Nimesulide Distributors List Table 196. Nimesulide Customers List Table 197. Nimesulide Market Trends Table 198. Nimesulide Growth Drivers Table 199. Nimesulide Market Restraints Table 200. Global Nimesulide Sales Forecast by Type (2022-2027) & (KG) Table 201. Global Nimesulide Sales Market Share Forecast by Type (2022-2027) Table 202. Global Nimesulide Revenue Forecast by Type (2022-2027) & (US$ Million) Table 203. Global Nimesulide Revenue Market Share Forecast by Type (2022-2027) Table 204. Global Nimesulide Sales Forecast by Application (2022-2027) & (KG) Table 205. Global Nimesulide Sales Market Share Forecast by Application (2022-2027) Table 206. Global Nimesulide Revenue Forecast by Application (2022-2027) & (US$ Million) Table 207. Global Nimesulide Revenue Market Share Forecast by Application (2022-2027) Table 208. Global Nimesulide Sales Forecast by Region (2022-2027) & (KG) Table 209. Global Nimesulide Sales Market Share Forecast by Region (2022-2027) Table 210. Global Nimesulide Revenue Forecast by Region (2022-2027) & (US$ Million) Table 211. Global Nimesulide Revenue Market Share Forecast by Region (2022-2027) Table 212. Research Programs/Design for This Report Table 213. Key Data Information from Secondary Sources Table 214. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Nimesulide Figure 2. Global Nimesulide Market Share by Type in 2020 & 2027 Figure 3. Tablets Product Picture Figure 4. Capsule Product Picture Figure 5. Granules Product Picture Figure 6. Other Product Picture Figure 7. Global Nimesulide Market Share by Application in 2020 & 2027 Figure 8. Chronic Arthritis Figure 9. Primary Dysmenorrhea Figure 10. Traumatic Pain Figure 11. Post-Operative Pain Figure 12. Other Figure 13. Global Nimesulide Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Nimesulide Market Size 2016-2027 (US$ Million) Figure 15. Global Nimesulide Sales 2016-2027 (KG) Figure 16. Global Nimesulide Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Nimesulide Sales Share by Manufacturers in 2020 Figure 18. Global Nimesulide Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Nimesulide Players: Market Share by Revenue in 2020 Figure 20. Nimesulide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Nimesulide Sales Market Share by Region (2016-2021) Figure 22. Global Nimesulide Sales Market Share by Region in 2020 Figure 23. Global Nimesulide Revenue Market Share by Region (2016-2021) Figure 24. Global Nimesulide Revenue Market Share by Region in 2020 Figure 25. U.S. Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. UAE Nimesulide Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Nimesulide by Type (2016-2021) Figure 50. Sales Market Share of Nimesulide by Application (2016-2021) Figure 51. Sales Market Share of Nimesulide by Application in 2020 Figure 52. Revenue Share of Nimesulide by Application (2016-2021) Figure 53. Revenue Share of Nimesulide by Application in 2020 Figure 54. Manufacturing Cost Structure of Nimesulide Figure 55. Manufacturing Process Analysis of Nimesulide Figure 56. Nimesulide Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us